Stay Ahead of the Competition - Free Exclusive Small Cap Reports Straight to Your Inbox


Citius Pharmaceuticals Inc.

 A Powerful Pipeline of Revolutionary Technology Has The Potential To Take This NASDAQ Opportunity From A 52 Week Low of  0.77 to its 10.00 Target INTRODUCING NASDAQ: CTXR CURRENT SENTIMENT ON BARCHART.COM ...

No posts to display